Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Applied Therapeutics, Inc. Director's Dealing 2024

Jun 7, 2024

34263_dirs_2024-06-07_35d09ff0-d02e-4ac0-b89c-97884c607c72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-06-06

Reporting Person: SKYLER JAY S (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-06 Common Stock A 45000 $0.00 Acquired 65000 Direct

Footnotes

F1: Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units shall vest on a quarterly basis from June 6, 2024 until the earlier of (i) the first anniversary of the date of grant and (ii) the date of the issuer's next annual stockholder meeting, in each case, subject to the reporting person's continuous service as of each such date.